PharmaShots | Incisive News in 3 Shots

Subscribe Now

DECLARE-TIMI 58

AstraZeneca's Forxiga (dapagliflozin) Receive NMPA's Approval for Label Update to Include Data of P-III DECLARE-TIMI 58 Study

AstraZeneca's Forxiga (dapagliflozin) Receive NMPA's Approval for Label Update to Include Data of P-III DECLARE-TIMI 58 Study

October 28, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us